NVAX公布即将参加两个投资者见面会。希望在此之前公布P3数据
GAITHERSBURG, Md., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in two upcoming investor conferences. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be the topic of discussion in each presentation.
J.P. Morgan 39th Annual Healthcare Conference
Presentation
Date:
Monday, January 11, 2021
Time:
8:20 a.m. Eastern Time (ET)
Presenters:
Stanley C. Erck, President and Chief Executive Officer and
Gregory M. Glenn, M.D., President, Research and Development
Webcast:
www.novavax.com, “Investors” / “Events”
Conference
Event:
Investor meetings
Date:
Monday, January 11, 2021 – Wednesday, January 13, 2021
13th Annual Biotech Showcase
Panel
Date:
Friday, January 8, 2021
Time:
11:00 a.m. Eastern Time (ET)
Panel title:
In Conversation with COVID-19 Leaders: The Novavax COVID-19 Journey
Moderator:
Kimberly Ha, Founder and Chief Executive Officer, KKH Advisors
Panelist:
John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer, Novavax
Webcast:
A replay of the recorded fireside session will be available through the events page of the Company’s website at ir.novavax.com for 90 days.